Dosing & Uses
Esophageal Carcinoma
Pending FDA approval for unresectable recurrent locally advanced or metastatic esophageal squamous cell carcinoma (ESCC) in people who had received prior systemic therapy
Next:
Pharmacology
Mechanism of Action
Humanized IgG4 anti-PD-1 monoclonal antibody
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
